GSK
GlaxoSmithKline PLC ADRNYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$102.18B
P/E Ratio
13.43
EPS
$3.79
Beta
0.30
52W High
$61.21
52W Low
$34.48
50-Day MA
$55.51
200-Day MA
$48.07
Dividend Yield
3.49%
Profit Margin
17.80%
Forward P/E
20.00
PEG Ratio
0.50
About GlaxoSmithKline PLC ADR
GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines, over-the-counter drugs and health-related consumer products in the UK, US and internationally. The company is headquartered in Brentford, the United Kingdom.
Fundamentals
| Revenue (TTM) | $32.78B |
| Gross Profit (TTM) | $23.89B |
| EBITDA | $11.43B |
| Operating Margin | 36.30% |
| Return on Equity | 40.90% |
| Return on Assets | 10.00% |
| Revenue/Share (TTM) | $16.25 |
| Book Value | $11.08 |
| Price-to-Book | 4.27 |
| Price-to-Sales (TTM) | 3.12 |
| EV/Revenue | 2.825 |
| EV/EBITDA | 9.18 |
| Quarterly Earnings Growth (YoY) | 8.40% |
| Quarterly Revenue Growth (YoY) | 1.50% |
| Shares Outstanding | $2.01B |
| Float | $3.89B |
| % Insiders | 0.06% |
| % Institutions | 19.67% |
Historical Volatility
HV 10-Day
32.00%
HV 20-Day
31.08%
HV 30-Day
29.69%
HV 60-Day
26.44%
HV Rank
67.9%
Volatility is currently expanding
Analyst Ratings
Consensus ($57.65 target)
1
Buy6
Hold1
SellMore HEALTHCARE Stocks
Data last updated: 5/5/2026